MADELINE POPLIN: Open Payments
NPI 1609613173 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 32 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $382 · 2025 $1,006
Food & beverage: $826Education: $180
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $233 |
| SEAGEN INC. | 2 | $180 |
| AstraZeneca Pharmaceuticals LP | 5 | $151 |
| ABBVIE INC. | 4 | $114 |
| Eisai Inc. | 3 | $68 |
| PFIZER INC. | 2 | $58 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Integra LifeSciences Corporation | 2 | $52 |
| Caris MPI, Inc. | 1 | $37 |
| Astellas Pharma US Inc | 1 | $34 |
Products named: LYNPARZA, ELAHERE, KEYTRUDA, Lenvima, TIVDAK, JEMPERLI, CODMAN CERTAS, MI CANCER SEEK.
Industry payments across VA — which companies pay providers there.
